Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007044832> ?p ?o ?g. }
- W2007044832 endingPage "281" @default.
- W2007044832 startingPage "274" @default.
- W2007044832 abstract "FLT3 is the most frequently mutated gene in cases of acute myelogenous leukemia (AML). About 30 to 35% of patients have either internal tandem duplications (ITDs) in the juxtamembrane domain or mutations in the activating loop of FLT3. FLT3 mutations occur in a broad spectrum of FAB subtypes in adult and pediatric AML and are particularly common in acute promyelocytic leukemia (APL). FLT3 mutations confer a poor prognosis in most retrospective studies. The consequence of either FLT3-ITD or activating loop mutations, which occur predominantly at position D835, is constitutive activation of the tyrosine kinase; FLT3 mutants confer factor-independent growth to Ba/F3 and 32D cells and activate similar transduction pathways as the native receptor in response to ligand, including the STAT, RAS/mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3; kinase (PI3K)/AKT pathways. Injection of FLT3-ITD transformed cells, such as Ba/F3 or 32D, into syngeneic recipient mice results in a leukemia-like syndrome, and expression in primary murine bone marrow cells in a retroviral transduction assay results in a myeloproliferative disorder. Mutations that abrogate FLT3 kinase activity result in loss of transforming properties in these assays. Further, FLT3-selective inhibitors impair transformation of primary AML cells that harbor these mutations, and also inhibit FLT3 transformed hematopoietic cell lines, and leukemias induced by activated FLT3 mutants in murine models. Collectively, these data indicate that FLT3 may be a viable therapeutic target for treatment of AML." @default.
- W2007044832 created "2016-06-24" @default.
- W2007044832 creator A5027429869 @default.
- W2007044832 creator A5075524302 @default.
- W2007044832 date "2002-07-01" @default.
- W2007044832 modified "2023-10-18" @default.
- W2007044832 title "Role of FLT3 in leukemia" @default.
- W2007044832 cites W134922517 @default.
- W2007044832 cites W148052780 @default.
- W2007044832 cites W1486112083 @default.
- W2007044832 cites W1506423591 @default.
- W2007044832 cites W1542395305 @default.
- W2007044832 cites W1579062391 @default.
- W2007044832 cites W1606912338 @default.
- W2007044832 cites W1625861579 @default.
- W2007044832 cites W1790518863 @default.
- W2007044832 cites W1835811038 @default.
- W2007044832 cites W1858218633 @default.
- W2007044832 cites W1905832649 @default.
- W2007044832 cites W194185434 @default.
- W2007044832 cites W1965950769 @default.
- W2007044832 cites W1968306285 @default.
- W2007044832 cites W1969366020 @default.
- W2007044832 cites W1971056717 @default.
- W2007044832 cites W1971833736 @default.
- W2007044832 cites W1978469902 @default.
- W2007044832 cites W1985349116 @default.
- W2007044832 cites W1990030298 @default.
- W2007044832 cites W1991155492 @default.
- W2007044832 cites W1991479256 @default.
- W2007044832 cites W1992388470 @default.
- W2007044832 cites W1994105285 @default.
- W2007044832 cites W1999614615 @default.
- W2007044832 cites W2004477791 @default.
- W2007044832 cites W2012661561 @default.
- W2007044832 cites W2014754106 @default.
- W2007044832 cites W2016127034 @default.
- W2007044832 cites W2017247060 @default.
- W2007044832 cites W2019093027 @default.
- W2007044832 cites W2026040088 @default.
- W2007044832 cites W2031295699 @default.
- W2007044832 cites W2032235066 @default.
- W2007044832 cites W2034618235 @default.
- W2007044832 cites W2034820298 @default.
- W2007044832 cites W2038950074 @default.
- W2007044832 cites W2040521097 @default.
- W2007044832 cites W2040950977 @default.
- W2007044832 cites W2050502992 @default.
- W2007044832 cites W2054210423 @default.
- W2007044832 cites W2054715911 @default.
- W2007044832 cites W2056295544 @default.
- W2007044832 cites W2059035027 @default.
- W2007044832 cites W2060245232 @default.
- W2007044832 cites W2067040747 @default.
- W2007044832 cites W2068770638 @default.
- W2007044832 cites W2071432029 @default.
- W2007044832 cites W2078481381 @default.
- W2007044832 cites W2082219113 @default.
- W2007044832 cites W2082706608 @default.
- W2007044832 cites W2085397716 @default.
- W2007044832 cites W2086404440 @default.
- W2007044832 cites W2086626683 @default.
- W2007044832 cites W2090549486 @default.
- W2007044832 cites W2092923321 @default.
- W2007044832 cites W2096185220 @default.
- W2007044832 cites W2106883237 @default.
- W2007044832 cites W2114410613 @default.
- W2007044832 cites W2128390662 @default.
- W2007044832 cites W2129615499 @default.
- W2007044832 cites W2129699438 @default.
- W2007044832 cites W2130039540 @default.
- W2007044832 cites W2130864403 @default.
- W2007044832 cites W2131627815 @default.
- W2007044832 cites W2136009584 @default.
- W2007044832 cites W2137333518 @default.
- W2007044832 cites W2138254417 @default.
- W2007044832 cites W2154987486 @default.
- W2007044832 cites W2157209890 @default.
- W2007044832 cites W2211134173 @default.
- W2007044832 cites W2253167439 @default.
- W2007044832 cites W2312804644 @default.
- W2007044832 cites W2317475893 @default.
- W2007044832 cites W2318118720 @default.
- W2007044832 cites W2321946412 @default.
- W2007044832 cites W2324850882 @default.
- W2007044832 cites W2325666068 @default.
- W2007044832 cites W2329648702 @default.
- W2007044832 cites W2331674116 @default.
- W2007044832 cites W2407963460 @default.
- W2007044832 cites W2465850963 @default.
- W2007044832 cites W4239183785 @default.
- W2007044832 cites W4245838825 @default.
- W2007044832 cites W4249310140 @default.
- W2007044832 cites W78744612 @default.
- W2007044832 doi "https://doi.org/10.1097/00062752-200207000-00003" @default.
- W2007044832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12042700" @default.
- W2007044832 hasPublicationYear "2002" @default.
- W2007044832 type Work @default.